HB 947: Patient-specific Prescription Drug Coverage Transparency
GENERAL BILL by Andrade
Patient-specific Prescription Drug Coverage Transparency; Provides patients are entitled to receive, upon request, specified information from a prescribing or ordering health care provider; specifies information certain insurers must provide to health care providers; authorizes health care providers to designate third party to facilitate exchange of such information; authorizes insurers to enter into agreements with designated third parties for specified purpose; provides limitations on such agreements.
Effective Date: 1/1/2023
Last Action: 3/14/2022 House - Died in Finance & Facilities Subcommittee
Bill Text: PDF
Last Action: 3/14/2022 House - Died in Finance & Facilities Subcommittee
Bill Text: PDF
-
Bill History
Date Chamber Action 12/16/2021 House • Filed
1/7/2022 House • Referred to Finance & Facilities Subcommittee
• Referred to Professions & Public Health Subcommittee
• Referred to Appropriations Committee
• Referred to Health & Human Services Committee
• Now in Finance & Facilities Subcommittee
1/11/2022 House • 1st Reading (Original Filed Version)
3/12/2022 House • Indefinitely postponed and withdrawn from consideration
3/14/2022 House • Died in Finance & Facilities Subcommittee
-
HB 947, Original Filed Version (Current Bill Version) Posted 12/16/2021 at 4:01 PM
Bill Text: PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 1290 Patient-specific Drug Coverage Transparency Gruters Similar Last Action: 3/14/2022 S Died in Health Policy 
Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 456.45 Page 1 (pdf)